Abstract: Anti-biofilm osseointegrating and/or tissue-integrating implantable biomaterial devices that optionally can elute therapeutic ions such as magnesium, silver, copper and/or zinc. In certain embodiments, the devices are engineered to produce structures suitable as implants having a relatively high surface population of zeolite. Methods of producing the devices are also disclosed.
Type:
Grant
Filed:
September 27, 2023
Date of Patent:
December 31, 2024
Assignee:
DiFusion, Inc.
Inventors:
Derrick Johns, Joseph J. Crudden, Sriram Sankar